Last Updated on October 10, 2024 by The Health Master
Lupin today received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA).
USFDA approves Rufinamide Tablets USP, 100 mg, 200 mg, and 400 mg, to market a generic equivalent of Banzel Tablets, 100 mg, 200 mg, and 400 mg, of Eisai Inc.
The product will be manufactured at Lupin’s facility in Goa, the statement added.
USFDA approves generic Vasopressin injection
USFDA gives approval for Meclizine HCL Tablets
USFDA gives nod for Prochlorperazine Maleate Tablets
USFDA gives approval generic Labetalol HCL tablets
USFDA gives final approval for Adapalene and Benzoyl Peroxide Topical Gel
USFDA gives final approval for Empagliflozin tablets
IPC adds 5 new IP Reference Standards & 7 new Impurities…
HP: Pharma units, Wholesalers, Chemist Shops under scanner of Anti Narcotic…
Dr VG Somani to continue as DCGI for next three months
USFDA approves generic Vasopressin injection
Drug alert: 53 out of 1337 samples declared as NSQ in July 2022
CDSCO Panel gives nod for clinical trial of Elagolix 150 mg for Endometriosis
This drug can fight more than 300 drug-resistant bacteria
20 Blood Banks fined ₹2.3cr for overcharging
Drug recall: Glenmark, Sun, Dr Reddy’s recalled these Drugs
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
